Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 30, 2020

View Archived Issues

Snake venom organoid gives toxin insights

Dosing initiated in first-in-human study of IK-175

Novel cynomolgus macaque model for Sudan virus disease

FDA approves Monoferric injection for the treatment of iron deficiency anemia

Erleada receives extended approval in Europe for metastatic hormone-sensitive prostate cancer

AgeX Therapeutics collaborates with Japanese biopharma to generate hypoimmunogenic cells

Spring Bank discontinues development of inarigivir and all HBV programs

Positive preliminary data from first patient in diverticulosis pilot trial of PGLG

Unum provides update on phase I study of ACTR-707 plus trastuzumab

H84T engineered banana lectin shows efficacy in influenza virus infection models

Pfizer presents phase I data for PF-04518600 in HCC

Phase II data presented for BPM-31510 plus gemcitabine in advanced PDAC

Novel coronavirus emerges rapidly; so does science

Guangzhou Wellhealth Bio-Pharmaceutical discloses new PD-1/PD-L1 inhibitors

Adenosine A2A/A2B antagonists patented by Jiangsu Hengrui Medicine, Shanghai Hengrui Pharmaceutical

Abbisko Therapeutics identifies PD-1/PD-L1 interaction inhibitors

New PD-1/PD-L1 interaction inhibitors presented by Betta Pharmaceuticals

CNRS and collaborators patent compounds for RNA virus infections

MicroCures advances burn wound healing collaborative research project

NIH grant supports Gladstone's investigation of how apoE4 causes neurodegeneration in Alzheimer's

EMD Serono studies M-1774 in first-in-human study for solid tumors

Cynomolgus macaque Marburg virus model developed using aerosol exposure

New phase II trial studies REGN-4461 for generalized lipodystrophy

Sanofi reports topline results with olipudase alfa in acid sphingomyelinase deficiency

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...